MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel and GAINESVILLE, Fla., March 05, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative ...

Functional electrical stimulation (FES) technology is a new type of treatment, which is through the simulation of the nerve on the muscle issued by the electrical signals for rehabilitation training.

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel and GAINESVILLE, Fla., March 05, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative ...

The global functional electrical stimulation market is estimated to be valued at USD 672.8 million in 2025 and is projected to reach USD 958.3 million by 2035, registering a compound annual growth ...

The global functional electrical stimulation market is poised for substantial growth, projected to rise from USD 672.8 million in 2025 to USD 958.3 million by 2035, registering a CAGR of 3.6% over the ...

Lifeward Ltd. and MYOLYN, Inc. have announced the expansion of their exclusive contract to enhance patient access to the MyoCycle FES Cycling Therapy System for home use. This collaboration aims to ...